Navigation Links
Spherix Awarded Grant from U.S. Government Under the Patient Protection and Affordable Care Act
Date:11/3/2010

ds equal to 50% of qualifying research and development expenses incurred during 2009 and 2010, up to an aggregate maximum of $5 million per applicant. Spherix applied for $5 million in the aggregate. The total award of $469,479 represents a pro rata reduction applied to all applicants, as the program was significantly over-subscribed. Spherix will receive the grant and recognize the full award during the fourth quarter of 2010.

About Spherix

Spherix Incorporated was launched in 1967 as a scientific research company under the name Biospherics Research. The Company now leverages its scientific and technical expertise and experience through its two subsidiaries – Biospherics Incorporated and Spherix Consulting, Inc. Biospherics recently completed a Phase 3 clinical trial to study the use of D-tagatose as a treatment for Type 2 diabetes. Its Spherix Consulting subsidiary provides scientific and strategic support for suppliers, manufacturers, distributors and retailers of conventional foods, biotechnology-derived foods, medical foods, infant formulas, food ingredients, dietary supplements, food contact substances, pharmaceuticals, medical devices, consumer products and industrial chemicals and pesticides. For more information, please visit www.spherix.com.

Forward-Looking Statements

This release contains forward-looking statements which are made pursuant to provisions of Section 21E of the Securities Exchange Act of 1934. Investors are cautioned that such statements in this release, including statements relating to planned clinical study design, regulatory and business strategies, plans and objectives of management and growth opportunities for existing or proposed products, constitute forward-looking statements which involve risks and uncertainties that could cause actual results to differ materially from those anticipated by the forward-looking statements. The risks and uncertainties i
'/>"/>

SOURCE Spherix Incorporated
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Spherix Reports Second Quarter Earnings
2. Growth Achieved in Spherixs Health Sciences Consulting Business
3. Spherix D-tagatose to be Supplied by Inalco SpA
4. Spherix Expands Phase 3 Naturlose Diabetes Trial Outside of the U.S.
5. Spherix Postpones 2009 Annual Shareholders Meeting to Share Interim Diabetes Clinical Trial Data
6. Spherix Elects New Independent Director, and Elects Chairman of the Board
7. Spherix Reports First Quarter 2009 Earnings
8. Spherix Announces Positive Phase 2 Study Results
9. Spherix Completes Enrollment in NEET, a Phase 3 Clinical Trial Evaluating an Oral Drug for Type 2 Diabetes
10. Spherix to Present at Annual OneMedPlace Finance Forum and at EBD Biotech Showcase in San Francisco
11. Spherix Reports Third Quarter 2009 Earnings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... India , June 19, 2013 ... Bureau has recently added DrugPatentWatch to ... ( http://www.bharatbook.com/drugpatentwatch-tour.pdf )      ... provides comprehensive information on pharmaceutical, drug ... information supports the critical business functions ...
(Date:6/19/2013)... 2013 DST Health Solutions, LLC (DSTHS), a ... plans, integrated delivery systems, and health care providers, has ... Service (MDMS) has jumped significantly. A ... pricing of medical prescription drug claims, MDMS ... medical drug claims processes. As specialty drug demand grows ...
(Date:6/19/2013)... , June 19, 2013   Life Technologies ... a licensing agreement granting Suzhou Ribo Life Sciences ... siRNA therapeutics in China ... formulate proprietary siRNA molecules in combination with Invivofectamine® ... address human diseases with high unmet medical need ...
Breaking Medicine Technology:Drug Patent Watch 2Drug Patent Watch 3Demand For DST's Medical Drug Management Service On The Rise As Health Plan Costs Increase 2Demand For DST's Medical Drug Management Service On The Rise As Health Plan Costs Increase 3Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 2Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 3Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 4
... (NYSE Amex: ANX ) announced today that it ... review development plans for ANX-188 (purified poloxamer 188), the Company,s ... ADVENTRX and the FDA discussed a variety of ... as the design of a phase 3 study for the ...
... 1, 2011 Advantage Home Telehealth (ADHT) announced ... to rapidly expand the deployment of the company,s ... open to insurance companies, physician groups, hospitals, clinics, ... interested in improving the quality and cost-effectiveness of ...
Cached Medicine Technology:ADVENTRX Meets with FDA to Discuss Development Plans for ANX-188 2ADVENTRX Meets with FDA to Discuss Development Plans for ANX-188 3Advantage Home Telehealth Launches Affiliate Program 2
(Date:6/19/2013)... 2013 The Journal of Parasitology – ... computer software, it creates questions of ethics. For scientific ... an already published case shows, scientific publications need clear ... The Journal of Parasitology features a commentary ... 2004 article published in the Journal of the New ...
(Date:6/19/2013)... international study led by researchers at The University of ... continues to show remarkable promise for the treatment of ... most recent interim findings of the 18-center Phase 2 ... Journal of Medicine . Previous interim findings were presented ... Hematology Annual Meeting and Exposition. , Unprecedented ...
(Date:6/19/2013)... in the June 19 online edition of the journal ... from the University of California, San Diego School of ... place when cardiac regeneration occurs in zebrafish after cardiac ... cell lines in the heart are more plastic, or ... thought. , More importantly, the research reveals a novel ...
(Date:6/19/2013)... Ore. A new understanding of the genetic process ... diagnosis of potentially dangerous lesions for some women, and ... anti-viral therapies in certain cases suggesting they could ... , The analysis provides a clearer picture of the ... human papillomavirus sometimes leads to chronic infection and, in ...
(Date:6/19/2013)... Iowa study reveals significant disparities between minority and ... abuse treatment programs. Moreover, these disparities vary widely ... suggest that for most states there,s something amiss," ... and biostatistics. "There are strong racial and ethnic ... substance abuse treatment programs successfully, and those disparities ...
Breaking Medicine News(10 mins):Health News:Altered Photo in Journal Article Illustrates the Need for Manipulation Guidelines 2Health News:Ibrutinib continues strong showing against mantle cell lymphoma 2Health News:Fate of the heart: Researchers track cellular events leading to cardiac regeneration 2Health News:Genetics of cervical cancer raise concern about antiviral therapy in some cases 2Health News:States vary widely on success rates for minorities in drug treatment programs 2Health News:States vary widely on success rates for minorities in drug treatment programs 3
... (IEEC) of the Binghamton University has received the ... York State Office of Science, Technology and Academic ... Microelectronics Research in the roll-to-roll format. ,NYSTAR’S ... initiatives, recognized by the New York State, especially ...
... Blue light tends to dissuade sleep, and it may be ... shifts, according to latest research reports. The alertness levels of ... the light they are working under, according to neuroscientist Steven ... ,Light contributes towards the wakefulness of a person. The ...
... the US who are as young as 13 years run the ... risk run by older people. // The study which took into ... were either overweight or about to become so. High blood sugar ... insulin levels were seen in the case of 36% of the ...
... Approaching Menopause? Losing your mind? Just pause and read ... Annual meeting of the International Neuropsychological Society, // suggests ... unforgettable. That means they might have huge difficulties remembering ... ,According to the study team, from the University of ...
... one can smell better when one is upright than when ... better sense of smell when they are sitting or standing. ... the Montreal Neurological Institute said that there is a significant ... ,Researchers at the McGill University institute conducted a ...
... Connecticut will be contacting police officers, school leaders, in ... pandemic influenza were to break out. // Officials belonging ... a situation. The fire department everywhere has to be ... been witness to several epidemics in the past which ...
Cached Medicine News:Health News:$ 1.7 Million NYSTAR Award for Binghamton University to Flex Electronics Research Muscle. 2Health News:Menopause pauses memory, posing unforgettable problems 2
Fulgurating Electrode, 3 F...
... The ACMI USA Series ACN-2 Flexible CystoNephroscope ... It is ideal for office practice. The ... accommodates a full range of operating instruments ... outer diameter, and beveled, UltraGlide covered tip ...
Inquire...
Used to obtain tissue biopsy under direct vision. Cup Biopsy Forceps are designed for use through rigid or flexible endoscopes. Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: